Navigation Links
Zeus Announces Product Name Changes
Date:2/10/2009

Zeus announces new product names that better reflect the unique properties and industry-leading characteristics of these products.

Orangeburg, SC (PRWEB) February 11, 2009 -- Zeus, Inc. announces new product name changes that signify its commitment to innovation and quality. The selected products are unaltered in composition and processing. They remain the same quality products that Zeus customers have come to expect and trust.

New brand names are as follows:

  • New trademarked product Aeos™, formerly known as ePTFE, is a micro-porous material that is medically implantable and has a low coefficient of friction. The new brand name Aeos was coined after the word "eon" to suggest the material's durability over an extended period of time.

  • New trademarked product Impactiv™, formerly known as Lubricious PEEK™, is a new version of PEEK tubing and can be used anywhere PEEK is used with a need for lower coefficient of friction. The material's new name suggests the product's excellent impact resistance.

  • New trademarked product Absorv™, formerly known as Zeus Biomaterial, receives its new brand name from its distinctive absorptive quality. These absorbable polymers have generated an extreme amount of interest due to their unique ability to perform vital functions in the body and safely absorb after they have carried out their function.

  • New trademarked product DuaTem™, formerly known as Hytem, is a flexible alternative to Ultem and is capable of operating at both high and low service temperatures. The new brand name reflects the dual properties of the product.

About Zeus, Inc.:
Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications; operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit www.zeusinc.com.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb1998804.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... 4, 2016 Beike Biotechnology, the ... attended a ceremony in late 2015 to mark their ... in 2016. --> --> ... for Personalized Cell Therapy" was hosted by the Shenzhen ... both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... 2016, to be held February 8-9, 2016, at the ... Disruptive Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ...
(Date:2/4/2016)... England , February 4, 2016 ... Bioscience Laboratories (ABL), Inc. --> Strasbourg, France ... Inc. --> PharmaVentures is pleased to announce that ... of its biopharmaceutical manufacturing unit in Strasbourg, France ... Inc. --> --> Transgene ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)...  Today, the first day of American Heart Month, ... a first of its kind workplace health solution that ... the first application of Watson ... and Welltok will create a new offering that combines ... delivered on Welltok,s health optimization platform. The effort is ...
(Date:1/28/2016)... 28, 2016 Synaptics (NASDAQ: SYNA ), a leading ... second quarter ended December 31, 2015. --> ... fiscal 2016 increased 2 percent compared to the comparable quarter last ... fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... for the first quarter of fiscal 2016 grew 9 percent over ...
Breaking Biology News(10 mins):